bioRxiv Science⌕ Search

Biology subjects

Sapir, L.

Publications and source records attributed to Sapir, L..

2 recordsLinked to original sources

Dynamics of Ligand Binding Sites and Chloride Penetration in a Bitter Taste GPCR

Taste perception strongly influences food choice, drug compliance, and dietary behavior. Bitter taste receptors belong to a subfamily of Family A GPCRs, while having unique features and deviations from conserved motifs. Recent CryoEM structures revealed that the human bitter taste receptor TAS2R14 contains not only the canonical extracellular binding site, but also a novel intracellular site, raising questions about their interplay. Using molecular dynamics simulations, we examined how binding of aristolochic acid in the intracellular site and cholesterol at the extracellular site, alone or together, affects receptor dynamics and pocket communication. We observed that cholesterol binding in the extracellular site expanded the intracellular pocket volume and induced conformational changes in TM6, whereas aristolochic acid binding in the intracellular site had no such effect on the extracellular site. Notably, in cholesterol-only simulations, a chloride ion entered from the intracellular side and interacted with Arginine 55 (BW position 2.50), revealing an inverted ion-binding pattern to Family A GPCRs, where aspartate 2.50 is known to bind a sodium ion to stabilize an inactive state. Our results suggest chloride-dependent and cholesterol-dependent modulation mechanisms in the dual-site dynamics of TAS2R14.

bioinformatics↗

Intracellular binding pocket revealed in the human bitter taste receptor TAS2R14

Bitter taste receptors (TAS2Rs), a subfamily of G-protein coupled receptors (GPCRs) expressed orally and extraorally, elicit signaling in response to a large set of ligands. Among the 25 functional TAS2Rs encoded in the human genome, TAS2R14 is the most promiscuous, and responds to hundreds of chemically diverse agonists. Here, we present the cryo-electron microscopy (cryo-EM) structure of the human TAS2R14 (hTAS2R14) in complex with its cognate signaling partner gustducin, and bound to flufenamic acid (FFA), a clinically approved nonsteroidal anti-inflammatory drug. The structure reveals an unusual binding mode for FFA, where two copies are bound at distinct binding pockets: one at the canonical GPCR site within the trans-membrane bundle, and the other in the intracellular facet, bridging the receptor with gustducin. Combined with site-directed mutagenesis and the design of a fluorescent FFA derivative for pocket-specific ligand binding BRET assays, our studies support a dual binding mode for FFA in TAS2R14. These results fill a gap in the understanding of bitter taste signaling and provide tools for guided design of TAS2R-targeted compounds.

biochemistry↗